228 related articles for article (PubMed ID: 35301360)
1. Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications.
Al Tbeishat H
Sci Rep; 2022 Mar; 12(1):4645. PubMed ID: 35301360
[TBL] [Abstract][Full Text] [Related]
2. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins.
Sharma R; Rajput VS; Jamal S; Grover A; Grover S
Sci Rep; 2021 Jul; 11(1):13836. PubMed ID: 34226593
[TBL] [Abstract][Full Text] [Related]
3. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against
Kumar A; Sharma P; Arun A; Meena LS
J Biomol Struct Dyn; 2023 May; 41(8):3382-3404. PubMed ID: 35293852
[TBL] [Abstract][Full Text] [Related]
4. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the whole proteome to design a novel mRNA-based vaccine against multidrug-resistant
Naveed M; Mughal MS; Jabeen K; Aziz T; Naz S; Nazir N; Shahzad M; Alharbi M; Alshammari A; Sadhu SS
Front Microbiol; 2022; 13():960285. PubMed ID: 36329838
[No Abstract] [Full Text] [Related]
6. In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD.
Shi J; Zhu Y; Yin Z; He Y; Li Y; Haimiti G; Xie X; Niu C; Guo W; Zhang F
Sci Rep; 2024 Mar; 14(1):7278. PubMed ID: 38538674
[TBL] [Abstract][Full Text] [Related]
7. A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1.
Naveed M; Ali U; Aziz T; Rasool MJ; Ijaz A; Alharbi M; Alharbi ME; Alshammari A; Alasmari AF
Acta Biochim Pol; 2023 Jun; 70(2):407-418. PubMed ID: 37329562
[TBL] [Abstract][Full Text] [Related]
8. Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17.
Moodley A; Fatoba A; Okpeku M; Emmanuel Chiliza T; Blessing Cedric Simelane M; Pooe OJ
Immunol Res; 2022 Aug; 70(4):501-517. PubMed ID: 35554858
[TBL] [Abstract][Full Text] [Related]
9. Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR.
Shiraz M; Lata S; Kumar P; Shankar UN; Akif M
Infect Genet Evol; 2021 Oct; 94():105017. PubMed ID: 34332157
[TBL] [Abstract][Full Text] [Related]
10. In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach.
Bhattacharjee M; Banerjee M; Mukherjee A
J Mol Model; 2023 Mar; 29(4):99. PubMed ID: 36928431
[TBL] [Abstract][Full Text] [Related]
11. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology.
Bibi S; Ullah I; Zhu B; Adnan M; Liaqat R; Kong WB; Niu S
Sci Rep; 2021 Jan; 11(1):1249. PubMed ID: 33441913
[TBL] [Abstract][Full Text] [Related]
12. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.
Medha ; Priyanka ; Sharma S; Sharma M
Eur J Pharm Sci; 2022 Jan; 168():106051. PubMed ID: 34744006
[TBL] [Abstract][Full Text] [Related]
13. In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis.
Martinez-Olivares CE; Hernández-Pando R; Mixcoha E
PLoS One; 2023; 18(4):e0284264. PubMed ID: 37079575
[TBL] [Abstract][Full Text] [Related]
14. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.
Logesh R; Lavanya V; Jamal S; Ahmed N
Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805
[TBL] [Abstract][Full Text] [Related]
15. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
[TBL] [Abstract][Full Text] [Related]
16. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach.
Ayyagari VS; T C V; K AP; Srirama K
J Biomol Struct Dyn; 2022 Apr; 40(7):2963-2977. PubMed ID: 33252008
[TBL] [Abstract][Full Text] [Related]
17. Computational design of experimentally validated multi-epitopes vaccine against hepatitis E virus: An immunological approach.
Anwar T; Ismail S; Parvaiz F; Abbasi SW; A Al-Abbasi F; M Alghamdi A; Al-Regaiey K; Ul-Haq A; Kaleem I; Bashir S; Waheed Y
PLoS One; 2023; 18(12):e0294663. PubMed ID: 38096182
[TBL] [Abstract][Full Text] [Related]
18. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
Nain Z; Karim MM; Sen MK; Adhikari UK
Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
[TBL] [Abstract][Full Text] [Related]
19. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach.
Abdulla F; Adhikari UK; Uddin MK
Microb Pathog; 2019 Dec; 137():103791. PubMed ID: 31606417
[TBL] [Abstract][Full Text] [Related]
20. A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches.
Negahdaripour M; Eslami M; Nezafat N; Hajighahramani N; Ghoshoon MB; Shoolian E; Dehshahri A; Erfani N; Morowvat MH; Ghasemi Y
Infect Genet Evol; 2017 Oct; 54():402-416. PubMed ID: 28780192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
